CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 1/1b First-in-Human, Open Label, Dose Escalation and Cohort Expansion Study of MGC026 in Participants With Advanced Solid Tumors
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06242470
- Title field or adapter rule
- {'original_value': 'A Phase 1/1b First-in-Human, Open Label, Dose Escalation and Cohort Expansion Study of MGC026 in Participants With Advanced Solid Tumors', 'source_field': 'protocolSection.identificationModule.officialTitle'}
- Ingested At
- 2026-10-31T23:27:21.727702+00:00
- Published At
- 2026-10-28T00:00:00+00:00
- Record Updated At
- 2026-10-28
- Source Retrieved At
- 2026-10-31T22:19:02.163121+00:00
- Timestamp Basis
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
- Date limitation
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Advanced Solid Tumor", "Advanced Cancer", "Metastatic Cancer", "Squamous Cell Carcinoma of Head and Neck", "Non Small Cell Lung Cancer", "Small-cell Lung Cancer", "Bladder Cancer", "Sarcoma", "Endometrial Cancer", "Melanoma", "Castration Resistant Prostatic Cancer", "Cervical Cancer", "Colorectal Cancer", "Gastric Cancer", "Gastro-esophageal Cancer", "Pancreas Cancer", "Clear Cell Renal Cell Carcinoma", "Hepatocellular Carcinoma", "Platinum-resistant Ovarian Cancer", "Breast Cancer", "Ovarian Cancer", "Esophageal Squamous Cell Cancer (SCC)"]- protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-28", "type": "ACTUAL"}- protocolSection.identificationModule.nctId
"NCT06242470"- protocolSection.identificationModule.officialTitle
"A Phase 1/1b First-in-Human, Open Label, Dose Escalation and Cohort Expansion Study of MGC026 in Participants With Advanced Solid Tumors"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct
null
Study condition terms
Interventions recorded in this study
- {'armGroupLabels': ['Module A Cohort 1', 'Module A Cohort 2', 'Module A Cohort 3', 'Module A Cohort 4', 'Module A Cohort 5', 'Module A Cohort 6'], 'description': 'Escalating doses of MGC026', 'name': 'MGC026 Dose Escalation', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Module A Expansion Cohort 5', 'Module A Expansion Cohort 6', 'Module A Expansion Cohort 7', 'Module A Expansion Cohort 8', 'Module A Expansion cohort 1', 'Module A Expansion cohort 2', 'Module A Expansion cohort 3', 'Module A Expansion cohort 4', 'Module B Part 1, Dose Level 2'], 'description': 'MGC026 recommended dose for expansion', 'name': 'MGC026 Dose for Expansion', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Module B Part 1, Dose Level 1', 'Module B Part 1, Dose Level 2'], 'description': '200 mg, IV, every 3 weeks.', 'name': 'Pembrollizumab', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Module B Part 1, Dose Level 1'], 'description': 'less than RDE dose level, IV, every 3 weeks', 'name': 'vobramitamab tavatecan', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
An intervention appearing in a study record does not establish an effect or an approved use.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.